Cell line · CVCL_0579
WI-38
Finite cell line, Homo sapiens. 75 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. WI-38. Cell lines, record CVCL_0579. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0579
On this page
Cell line
As Cellosaurus gives it.
- Name
- WI-38
- Accession
- CVCL_0579
- RRID
- RRID:CVCL_0579
- Synonyms
- Wi-38, WI 38, WI38, Wistar Institute-38, AG06814E, AG06814G, AG06814H, AG06814-J, AG06814J, AG06814-M, AG06814-N
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 16FW
- Category
- Finite cell line
- Derived from
- Fetal lung (in situ)
- Cell type
- Fibroblast of lung
- Entry created
- 2012-04-04
- Entry updated
- 2025-11-27
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers75
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Selective elimination of quiescent cancer cells by dequalinium chloride via ROS-mediated ferroptosis. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Acute LINE-1 overexpression rewires the transcriptome, proteome and secretome of primary human fibroblasts. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Contractile perinuclear actomyosin network promotes peripheral and polar chromosome interaction with the mitotic spindle. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Decreased Glucose Metabolism and Declined Chaperones Are Unique Features Required for the Survival of Senescent Fibroblasts and Pyruvate Dehydrogenase Is a Potent Senolytic Target. | Aging Cell | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative CRISPR Screening and RNA Analyses Discover an Essential Role for PUF60 Interactions with 3' Splice Sites in Cancer Progression. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel Quinolone JH62 (E-2-(Tridec-4-en-1-yl)-quinolin-4(1H)-one) from Pseudomonas aeruginosa Exhibits Potent Anticancer Activity. | Microorganisms | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A Reporter Platform to Study Therapy-Induced Senescence in Live Cancer Cells. | Small Methods | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 75
See all 75 papersRelatives16
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | GM08854 | CVCL_1R80 | Cell lines | |
| Derived from it | GM10322 | CVCL_1R88 | Cell lines | |
| Derived from it | GM10323 | CVCL_1R89 | Cell lines | |
| Derived from it | PSV811 | CVCL_3142 | Has a recorded problem | Cell lines |
| Derived from it | UTHs | CVCL_7871 | Cell lines | |
| Derived from it | WI-38 (HSV-2)Tr | CVCL_YU09 | Cell lines | |
| Derived from it | WI-38 CT-1 | CVCL_L281 | Cell lines | |
| Derived from it | WI-38 Tr | CVCL_5605 | Cell lines | |
| Derived from it | WI-38 VA13 subline 2RA | CVCL_2759 | Cell lines | |
| Derived from it | WI-38-30 | CVCL_2812 | Cell lines |
1 to 10 of 16
See all 16 relativesCell banks17
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CCL-75 | ATCC | |
| ATCC | CRL-7728 | Discontinued | Cellosaurus |
| AddexBio | T0016037/5007 | Cellosaurus | |
| CCTCC | GDC0016 | Cellosaurus | |
| CLS | 300428 | CLS | |
| Coriell | AG06814-J | Coriell | |
| Coriell | AG06814-M | Coriell | |
| Coriell | AG06814-N | Coriell | |
| ECACC | 90020107 | ECACC | |
| IZSLER | BS CL 90 | Cellosaurus |
1 to 10 of 17
See all 17 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0579
GET https://conductscience.org/api/cell-lines/v1/CVCL_0579/papers?page=2